MedPath

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)

Phase 2
Conditions
Chronic Hepatitis b
Interventions
First Posted Date
2019-12-17
Last Posted Date
2019-12-19
Lead Sponsor
Tongji Hospital
Target Recruit Count
30
Registration Number
NCT04202653

A Real-world Study for Patients With Multiple Pulmonary Ground-glass Nodules

Not yet recruiting
Conditions
Multiple Pulmonary Nodules
First Posted Date
2019-12-10
Last Posted Date
2019-12-10
Lead Sponsor
Tongji Hospital
Target Recruit Count
200
Registration Number
NCT04192201
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer

Phase 2
Conditions
Esophagus Cancer
Interventions
Drug: Teripalimab
First Posted Date
2019-11-26
Last Posted Date
2019-11-26
Lead Sponsor
Tongji Hospital
Target Recruit Count
44
Registration Number
NCT04177875
Locations
🇨🇳

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

Prediction of Sepsis After Flexible Ureteroscopy

Completed
Conditions
Urolithiasis
Surgery--Complications
Sepsis
Interventions
Procedure: flexible ureteroscopy
First Posted Date
2019-11-08
Last Posted Date
2019-11-08
Lead Sponsor
Tongji Hospital
Target Recruit Count
759
Registration Number
NCT04157452
Locations
🇨🇳

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
Prostatic Neoplasms
Interventions
Procedure: Radical Prostatectomy
Other: Radical Radiotherapy
First Posted Date
2019-09-18
Last Posted Date
2019-10-24
Lead Sponsor
Tongji Hospital
Target Recruit Count
600
Registration Number
NCT04093375

Sufentanil on Anesthesia Introduction and Recovery Quality in Pediatric Adenotonsillectomy

Not Applicable
Completed
Conditions
Sufentanil
Interventions
First Posted Date
2019-08-26
Last Posted Date
2023-01-10
Lead Sponsor
Tongji Hospital
Target Recruit Count
90
Registration Number
NCT04067648
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules

Phase 2
Not yet recruiting
Conditions
Multiple Pulmonary Nodules
Interventions
First Posted Date
2019-08-06
Last Posted Date
2019-08-06
Lead Sponsor
Tongji Hospital
Target Recruit Count
50
Registration Number
NCT04047186
Locations
🇨🇳

Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan, Hubei, China

Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients

Not Applicable
Conditions
Ulcerative Colitis
Interventions
Procedure: Standardized Quantitative multi-donor Intestinal Microbiota Capsule (SQIMC-md)
Procedure: placebo capsule
First Posted Date
2019-07-26
Last Posted Date
2019-08-13
Lead Sponsor
Tongji Hospital
Target Recruit Count
99
Registration Number
NCT04034758

A Study on Nutrition Support Therapy of Patients With Liver Failure

Not Applicable
Conditions
Nutrition
Interventions
Dietary Supplement: standard hospital diet
First Posted Date
2019-05-09
Last Posted Date
2019-05-09
Lead Sponsor
Tongji Hospital
Target Recruit Count
100
Registration Number
NCT03944330

Glecaprevir/Pibrentasvir Real-world Study in China

Conditions
Chronic Hepatitis c
Interventions
First Posted Date
2019-05-08
Last Posted Date
2019-05-08
Lead Sponsor
Tongji Hospital
Target Recruit Count
800
Registration Number
NCT03941821
© Copyright 2025. All Rights Reserved by MedPath